bromocriptine has been researched along with medroxyprogesterone in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (84.21) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Goldfine, ID | 1 |
| Di Carlo, F; Dogliotti, L; Mussa, A | 2 |
| Ichikawa, Y; Kawagoe, M; Yoshida, K | 1 |
| Ginsburg, J; Havard, CW | 1 |
| Franks, S; Hull, MG; Jacobs, HS; Murray, MA; Nabarro, JD; Steele, SJ | 1 |
| Jacobs, H | 1 |
| Dauvois, S; Labrie, F; Spinola, PG | 1 |
| Abel, U; Edler, L; Fritze, D; Kaufmann, M; Massner, B; Queisser, W; Schmid, H; Schmidt, R; Westerhausen, M | 1 |
| Bellussi, G; Conti, G; Di Carlo, F; Muccioli, G; Racca, S | 1 |
| Farabegoli, G; Martoni, A; Pannuti, F; Piana, E | 1 |
| Huber, H; Schmidt, JB; Spona, J | 1 |
| Kauppila, A | 1 |
| Alabisco, O; Dogliotti, L; Mussa, A; Sacchetto, GP | 1 |
| Ory, SJ; Puleo, JG | 1 |
| Belforte, L; Lanza, MG; Lotano, MR; Peris, C; Prelato, L | 1 |
5 review(s) available for bromocriptine and medroxyprogesterone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Medical treatment of acromegaly.
Topics: Acromegaly; Adrenergic alpha-Agonists; Bromocriptine; Estrogens; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Medroxyprogesterone; Serotonin Antagonists; Somatostatin | 1978 |
Polycystic ovary syndrome.
Topics: Bromocriptine; Clomiphene; Dexamethasone; Diagnosis, Differential; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Ketosteroids; Luteinizing Hormone; Medroxyprogesterone; Ovary; Polycystic Ovary Syndrome; Prednisone; Testosterone; Time Factors | 1976 |
Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Forecasting; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Neoplasm Recurrence, Local; Ovarian Neoplasms; Progestins; Receptors, Steroid; Uterine Neoplasms | 1984 |
[Male breast carcinoma. Review of the literature and report of cases].
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Bromocriptine; Carcinoma, Intraductal, Noninfiltrating; Humans; Immunotherapy; Male; Medroxyprogesterone; Middle Aged | 1982 |
1 trial(s) available for bromocriptine and medroxyprogesterone
| Article | Year |
|---|---|
Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperprolactinemia; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Prolactin; Vincristine | 1986 |
13 other study(ies) available for bromocriptine and medroxyprogesterone
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
[Preliminary results of treatment of hormone-dependent metastatic carcinoma of the breast with the bromocriptin-medroxyprogesterone acetate combination].
Topics: Adult; Aged; Breast Neoplasms; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Female; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen | 1977 |
[Treatment of acromegaly using CB-154 and medroxy-progesterone acetate].
Topics: Acromegaly; Bromocriptine; Growth Hormone; Humans; Male; Medroxyprogesterone; Middle Aged | 1977 |
Clinical and endocrine features of hyperprolactinaemic amenorrhoea.
Topics: Adult; Amenorrhea; Bromocriptine; Clomiphene; Estradiol; Female; Follicle Stimulating Hormone; Galactorrhea; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Menstruation; Ovulation; Pituitary Neoplasms; Pregnancy; Progesterone; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine | 1976 |
The investigation and management of amenorrhoea.
Topics: Amenorrhea; Bromocriptine; Clomiphene; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone; Prolactin | 1977 |
Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Drug Synergism; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone | 1989 |
High tumour prolactin receptor content and lack of increase in serum prolactin levels as predictors of good response to endocrine therapy in rat mammary cancer.
Topics: Adenocarcinoma; Animals; Bromocriptine; Female; Liver; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Prolactin; Rats; Rats, Inbred Strains; Receptor, Insulin; Receptors, Prolactin | 1988 |
Prolactin levels and hormonal profile in postmenopausal patients with advanced breast cancer during endocrine treatments.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Delayed-Action Preparations; Estradiol; Female; Gonadotropins, Pituitary; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prolactin; Tamoxifen; Testosterone; Thyroid Hormones | 1985 |
[Therapeutic possibilities in hirsutism].
Topics: Androgens; Bromocriptine; Dexamethasone; Female; Hirsutism; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate | 1984 |
Nonpuerperal mastitis associated with galactorrhea.
Topics: Adult; Bromocriptine; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Lactation Disorders; Luteinizing Hormone; Mastitis; Medroxyprogesterone; Polycystic Ovary Syndrome; Pregnancy; Prolactin; Staphylococcus aureus; Thyroxine; Triiodothyronine | 1983 |
[Cyclic treatment of "functional" amenorrheas with MAP].
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Clomiphene; Cyclofenil; Epimestrol; Estrogens; Female; Humans; Medroxyprogesterone; Progestins | 1983 |
[Overall evaluation of the results of treatment of metastatic carcinomas of the breast with high doses of MAP combined with bromocryptin].
Topics: Adult; Aged; Breast Neoplasms; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis | 1980 |